StockTipsArenaBeta

BUY Global Health Limited — Narendra Solanki, Anand Rathi

BUYGlobal Health Limited

byNarendra Solanki, Anand RathiHorizon: NA (inferred 1 year)4 Aug 2026via CNBC Awaaz.

Entry₹1,430.9Inferred
Target₹1,550
Total upside +8.32%
Stop lossNot given
CMP₹1,447.2Just now
Active+1.14%+7.10%upside left 11 mo left
Follow Narendra Solanki for new callsGet alertsWatch MEDANTA for new buy/sell callsGet alertsSee 3 other Long-term calls on MEDANTASee 1 other Long-term pick this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 14 Sept, 5:03 pm IST
21 supporting8 neutral3 opposing
Supports the BUY call (21)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·11 Sept · 3d ago

Medanta reports record Q1FY27 revenue, Noida losses narrow sharply

NewsGoogle News·9 Sept · 5d ago

(opens in new tab)

2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·1 Sept · 2w ago

Global Health Limited Reports Earnings Results for the Full Year Ended June 30, 2026

NewsGoogle News·27 Aug · 3w ago

(opens in new tab)

Global Health boosts SaaS revenue and trims costs in FY2026 upgrade

NewsGoogle News·27 Aug · 3w ago

(opens in new tab)
Neutral / worth noting (8)

Global Health hosts analyst meetings with Polar Capital and Chikara

NewsGoogle News·3 Sept · 1w ago

(opens in new tab)

Global Health Plans Analyst and Investor Meetings

NewsGoogle News·3 Sept · 1w ago

(opens in new tab)
Weighs against the BUY call (3)

Global Health Limited (ASX:GLH): What Comes Next After a Sharp Session Decline?

NewsGoogle News·2 Sept · 2w ago

(opens in new tab)

Global Health Loss Narrows but Going-Concern Doubts Persist

NewsGoogle News·27 Aug · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.